tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Shrader, 130 are a BUY (89.04%), 14 are a HOLD (9.59%), 2 are a SELL (1.37%).
Analyst Thomas Shrader, currently employed at BTIG, carries an average stock price target met ratio of 53.53% that have a potential upside of 47.86% achieved within 269 days.
Thomas Shrader’s has documented 276 price targets and ratings displayed on 42 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALEC, Alector at 25-Sep-2025.
Analyst best performing recommendations are on VRNA (VERONA PHARMA PLC ADR).
The best stock recommendation documented was for VRNA (VERONA PHARMA PLC ADR) at 12/20/2022. The price target of $26 was fulfilled within 10 days with a profit of $7.41 (39.86%) receiving and performance score of 39.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$70
$17.14 (32.43%)
$70
24 days ago
(14-Sep-2025)
22/29 (75.86%)
$18.53 (36.00%)
309
Buy
$82
$29.14 (55.13%)
$72
27 days ago
(11-Sep-2025)
4/8 (50%)
$30.79 (60.12%)
342
Buy
$70
$17.14 (32.43%)
$50
1 months 6 days ago
(02-Sep-2025)
13/15 (86.67%)
$18.16 (35.03%)
176
Buy
$61
$8.14 (15.40%)
$60
2 months 3 days ago
(05-Aug-2025)
0/2 (0%)
$16.19 (36.13%)
Buy
$57
$4.14 (7.83%)
$55
2 months 3 days ago
(05-Aug-2025)
8/10 (80%)
$12.19 (27.20%)
219
Which stock is Thomas Shrader is most bullish on?
Which stock is Thomas Shrader is most reserved on?
What Year was the first public recommendation made by Thomas Shrader?
